EGEGazette
Live
Iran Confirms Receipt of US Proposal, Government Spokesperson SaysHurricane Polo's Remnants Bring More Flooding to US SouthwestUS Supreme Court Temporarily Allows Resumption of Migrant DeportationsUS Supreme Court Allows Trump Administration to Resume Third-Country DeportationsUS-Led Anti-Jihadist Coalition Completes Troop Withdrawal from IraqAmid fears of a security vacuum, US forces withdraw from IraqAxios: US-Iran Talks Mediated by Qatar Hit an ImpasseAfter more than 20 years of presence, the last US soldiers leave Iraq30-Year Treasury Yield Climbs to Highest Level Since 2002US Troops Complete Withdrawal From Baghdad Base After Two DecadesSupreme Court Allows Trump Administration to Resume Third-Country DeportationsConservative Supreme Court Majority Lifts Block on Trump's Third-Country Deportations, Liberal Justices Dissent
HealthAI AnalysisReported

Japan launches commercial use of stem cell heart therapy

A Japanese hospital performed the first transplant of cardiac cell sheets derived from stem cells using a commercially approved treatment.

By EGazette AI · · 2 min read · language: en

Written by EGazette’s AI. The facts are drawn from cited sources; the analysis is the AI’s own.

Article image
— Sky News Arabia — Technology

Japan has launched the commercial use of a new stem cell-based heart treatment, after a Japanese hospital performed what has been described as the world's first surgery to transplant sheets of cardiac muscle cells derived from stem cells.

According to one of the surgeons involved in the procedure, this treatment has received conditional government approval allowing it to be offered for commercial use — a world first in this medical field.

A promising technology

The technique involves transplanting thin sheets made of cardiac muscle cells derived from stem cells, with the aim of helping repair or regenerate damaged heart tissue in patients suffering from heart disease.

Full details regarding the number of patients targeted by this treatment or the associated costs have not yet been disclosed, as the medical community awaits further data on the initial outcomes of the procedure that was performed.

This step comes in the context of ongoing Japanese efforts to develop advanced stem cell-based therapies, with Japan considered one of the world's leading countries in regenerative medicine research for many years.

Specialists believe that the success of this type of therapy could open the door to similar applications for treating other conditions that require the repair or regeneration of damaged tissue, though the matter still requires further long-term studies and follow-up to evaluate its efficacy and safety on a wider scale.

Japanese authorities have not yet set a timeline for expanding the use of this treatment to include other hospitals within the country or abroad.

Sources

EGazette summarizes reporting from multiple sources; follow the links for the originals.

Also available in: ARESFRRUTRUR

Comments

Sign in to join the conversation.

Forgot password?

No account?

Loading comments…

Related articles